Nakagawa Kiyotaka, Oak Jeong-Ho, Miyazawa Teruo
Food and Biodynamic Chemistry Laboratory, Graduate School of Agricultural Science, Tohoku University, Sendai 981-8555, Japan.
Ann N Y Acad Sci. 2005 Jun;1043:413-6. doi: 10.1196/annals.1333.048.
Glycation has been thought to participate in diabetic vascular diseases. However, there are no reports about the effects of lipid glycation on endothelial dysfunction. In this study, we have evaluated whether Amadori-glycated phosphatidylethanolamine (Amadori-PE), a lipid-linked glycation compound, affected proliferation, migration, and tube formation of cultured human umbilical vein endothelial cells. These three factors involved in angiogenesis were significantly stimulated by Amadori-PE at a low concentration of less than 5 microM. Furthermore, Amadori-PE also stimulated the secretion of matrix metalloproteinase-2 (MMP-2), a pivotal enzyme in the initial step of angiogenesis. Our results indicated for the first time that Amadori-PE would elicit vascular disease through angiogenic potency on endothelial cells, thereby playing an active part in the development and progression of diabetic microangiopathy.
糖化作用被认为与糖尿病血管疾病有关。然而,关于脂质糖化对内皮功能障碍影响的报道却很少。在本研究中,我们评估了一种脂质连接的糖化化合物——阿马多里糖化磷脂酰乙醇胺(Amadori-PE)是否会影响培养的人脐静脉内皮细胞的增殖、迁移和管腔形成。在浓度低于5微摩尔的低浓度下,阿马多里糖化磷脂酰乙醇胺(Amadori-PE)能显著刺激血管生成所涉及的这三个因素。此外,阿马多里糖化磷脂酰乙醇胺(Amadori-PE)还能刺激基质金属蛋白酶-2(MMP-2)的分泌,MMP-2是血管生成初始步骤中的关键酶。我们的结果首次表明,阿马多里糖化磷脂酰乙醇胺(Amadori-PE)可通过对内皮细胞的血管生成能力引发血管疾病,从而在糖尿病微血管病变的发生和发展中发挥积极作用。